Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.所揭示者為用於治療受到MALT1調節所影響之疾病、症候群、病況、及病症之化合物、組成物及方法。該等化合物係由以下式(I)表示: 其中R1、R2、R3、R4、R5、R6、R5、G1、及G2係如本文中所定義。